Search

everythinglearnresearchcommunity

for

Search:↓

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Testosterone plus finasteride increases bone density in men with spinal cord injuries.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone therapy increases bone density in older men with low testosterone levels.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Finasteride doesn't harm bone density in older men with BPH.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.